Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Post-discharge heart failure monitoring program in Turkey: Hit-PoinT.

Çavuşoğlu Y, Zoghi M, Eren M, Bozçalı E, Kozdağ G, Şentürk T, Alicik G, Soylu K, Sarı İ, Berilgen R, Temizhan A, Gencer E, Orhan AL, Polat V, Aydın Kaderli A, Aktoz M, Zengin H, Aksoy M, Selçuk MT, Ergene O, Soran Ö; Hit-PoinT Investigators.

Anatol J Cardiol. 2017 Feb;17(2):107-112. doi: 10.14744/AnatolJCardiol.2016.6812. Epub 2016 Jul 26.

2.

Alternative Therapy for Medically Refractory Angina: Enhanced External Counterpulsation and Transmyocardial Laser Revascularization.

Soran O.

Heart Fail Clin. 2016 Jan;12(1):107-16. doi: 10.1016/j.hfc.2015.08.009. Review.

PMID:
26567978
3.

No association between left-breast radiation therapy or breast arterial calcification and long-term cardiac events in patients with breast cancer.

Soran O, Vargo JA, Polat AV, Soran A, Sumkin J, Beriwal S.

J Womens Health (Larchmt). 2014 Dec;23(12):1005-11. doi: 10.1089/jwh.2014.4748.

PMID:
25470126
4.

Alternative therapy for medically refractory angina: enhanced external counterpulsation and transmyocardial laser revascularization.

Soran O.

Cardiol Clin. 2014 Aug;32(3):429-38. doi: 10.1016/j.ccl.2014.04.009. Review.

PMID:
25091968
5.

Standing the test of time: exercise testing for heart failure prognosis in the beta-blocker era.

Simon M, Soran O.

Turk Kardiyol Dern Ars. 2013 Mar;41(2):113-4. doi: 10.5543/tkda.2013.08504. No abstract available.

6.

Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus.

Soran O.

Curr Cardiol Rep. 2013 Jan;15(1):323. doi: 10.1007/s11886-012-0323-5. Review.

PMID:
23250660
7.

Comparison of long term clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation for coronary artery disease in the United States and Turkey.

Soran O, Ikizler C, Sengül A, Cuğlan B, Kennard E, Kelsey S.

Turk Kardiyol Dern Ars. 2012 Jun;40(4):323-30. doi: 10.5543/tkda.2012.59144.

8.

Pulsatile venous waveform quality in Fontan circulation-clinical implications, venous assists options and the future.

Koçyıldırım E, Dur O, Soran O, Tüzün E, Miller MW, Housler GJ, Wearden PD, Fossum TW, Morell VO, Pekkan K.

Anadolu Kardiyol Derg. 2012 Aug;12(5):420-6. doi: 10.5152/akd.2012.126. Epub 2012 May 16.

9.

Clinical effects of enhanced external counterpulsation treatment in patients with ischemic heart failure.

Kozdağ G, Ertaş G, Aygün F, Emre E, Kirbaş A, Ural D, Soran O.

Anadolu Kardiyol Derg. 2012 May;12(3):214-21. doi: 10.5152/akd.2012.064. Epub 2012 Feb 24.

10.

Pulsatile venous waveform quality affects the conduit performance in functional and "failing" Fontan circulations.

Dur O, Kocyildirim E, Soran O, Wearden PD, Morell VO, DeGroff CG, Pekkan K.

Cardiol Young. 2012 Jun;22(3):251-62. doi: 10.1017/S1047951111001491. Epub 2011 Oct 19.

PMID:
22008697
11.

[Frequency of sublingual nitroglycerin prescription in patients with coronary artery disease and angina and awareness of patients about the shelf life of the drug].

Yılmaz OC, Keskin G, Cuğlan B, Selçoki Y, Temizkan A, Eryonucu B, Soran O.

Turk Kardiyol Dern Ars. 2011 Sep;39(6):469-73. doi: 10.5543/tkda.2011.01635. Turkish.

12.

Management of refractory angina pectoris.

Manchanda A, Aggarwal A, Aggarwal N, Soran O.

Cardiol J. 2011;18(4):343-51. Review.

13.

Cost of medical services in older patients with heart failure: those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: the Heart Failure Home Care trial.

Soran OZ, Feldman AM, Piña IL, Lamas GA, Kelsey SF, Selzer F, Pilotte J, Lave JR.

J Card Fail. 2010 Nov;16(11):859-66. doi: 10.1016/j.cardfail.2010.05.028.

PMID:
21055649
14.

Effects of isolated obesity on left and right ventricular function: a tissue Doppler and strain rate imaging study.

Orhan AL, Uslu N, Dayi SU, Nurkalem Z, Uzun F, Erer HB, Hasdemir H, Emre A, Karakus G, Soran O, Gorcsan J 3rd, Eren M.

Echocardiography. 2010 Mar;27(3):236-43. doi: 10.1111/j.1540-8175.2009.01024.x. Epub 2009 Jan 13.

PMID:
20070359
15.

Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current perspective.

Soran O, Manchanda A, Schueler S.

Interact Cardiovasc Thorac Surg. 2009 Jun;8(6):666-71. doi: 10.1510/icvts.2008.195644. Epub 2009 Mar 23. Review.

PMID:
19307243
16.

Treatment options for refractory angina pectoris: enhanced external counterpulsation therapy.

Soran O.

Curr Treat Options Cardiovasc Med. 2009 Feb;11(1):54-60.

PMID:
19141261
17.

A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women.

Soran OZ, Piña IL, Lamas GA, Kelsey SF, Selzer F, Pilotte J, Lave JR, Feldman AM.

J Card Fail. 2008 Nov;14(9):711-7. doi: 10.1016/j.cardfail.2008.06.448. Epub 2008 Aug 9.

PMID:
18995174
18.

Passive tobacco exposure may impair symptomatic improvement in patients with chronic angina undergoing enhanced external counterpulsation.

Efstratiadis S, Kennard ED, Kelsey SF, Michaels AD; International EECP Patient Registry-2 Investigators.

BMC Cardiovasc Disord. 2008 Sep 17;8:23. doi: 10.1186/1471-2261-8-23.

19.

Effect of the soluble TNF-antagonist etanercept on tumor necrosis factor bioactivity and stability.

Mann DL, Bozkurt B, Torre-Amione G, Soran OZ, Sivasubramanian N.

Clin Transl Sci. 2008 Sep;1(2):142-5. doi: 10.1111/j.1752-8062.2008.00013.x.

20.

Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry.

Loh PH, Cleland JG, Louis AA, Kennard ED, Cook JF, Caplin JL, Barsness GW, Lawson WE, Soran OZ, Michaels AD.

Clin Cardiol. 2008 Apr;31(4):159-64. doi: 10.1002/clc.20117.

Supplemental Content

Loading ...
Support Center